Neurocrine Biosciences Inc (NASDAQ:NBIX)

43.37
Delayed Data
As of Apr 24
 -0.31 / -0.71%
Today’s Change
12.63
Today|||52-Week Range
45.36
+94.14%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close43.68
Today’s open43.54
Day’s range43.01 - 44.10
Volume358,730
Average volume (3 months)1,044,400
Market cap$3.7B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-23.41%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book15.89

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.53-1.06%
ACADACADIA Pharmaceutica...-0.54-1.39%
ASPXAuspex Pharmaceutica...-0.01-0.01%
CLVSClovis Oncology Inc+1.78+1.97%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers